IBDEI0D8 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5972,1,2,0)
 ;;=2^90703
 ;;^UTILITY(U,$J,358.3,5972,1,3,0)
 ;;=3^TETANUS VACCINE IM
 ;;^UTILITY(U,$J,358.3,5973,0)
 ;;=90732^^29^399^5^^^^1
 ;;^UTILITY(U,$J,358.3,5973,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5973,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,5973,1,3,0)
 ;;=3^PNEUMOCOCCAL VACCINE
 ;;^UTILITY(U,$J,358.3,5974,0)
 ;;=86580^^29^399^6^^^^1
 ;;^UTILITY(U,$J,358.3,5974,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5974,1,2,0)
 ;;=2^86580
 ;;^UTILITY(U,$J,358.3,5974,1,3,0)
 ;;=3^TB INTRADERMAL TEST
 ;;^UTILITY(U,$J,358.3,5975,0)
 ;;=90658^^29^399^1^^^^1
 ;;^UTILITY(U,$J,358.3,5975,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5975,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,5975,1,3,0)
 ;;=3^FLU VACCINE
 ;;^UTILITY(U,$J,358.3,5976,0)
 ;;=90715^^29^399^7^^^^1
 ;;^UTILITY(U,$J,358.3,5976,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5976,1,2,0)
 ;;=2^90715
 ;;^UTILITY(U,$J,358.3,5976,1,3,0)
 ;;=3^Tdap Vaccine
 ;;^UTILITY(U,$J,358.3,5977,0)
 ;;=90999^^29^400^1^^^^1
 ;;^UTILITY(U,$J,358.3,5977,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5977,1,2,0)
 ;;=2^90999
 ;;^UTILITY(U,$J,358.3,5977,1,3,0)
 ;;=3^Daily Dialysis Treatment
 ;;^UTILITY(U,$J,358.3,5978,0)
 ;;=90935^^29^401^1^^^^1
 ;;^UTILITY(U,$J,358.3,5978,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5978,1,2,0)
 ;;=2^90935
 ;;^UTILITY(U,$J,358.3,5978,1,3,0)
 ;;=3^HEMODIALYSIS SINGLE EVAL
 ;;^UTILITY(U,$J,358.3,5979,0)
 ;;=90937^^29^401^2^^^^1
 ;;^UTILITY(U,$J,358.3,5979,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5979,1,2,0)
 ;;=2^90937
 ;;^UTILITY(U,$J,358.3,5979,1,3,0)
 ;;=3^HEMODIALYSIS REPEATED EVAL
 ;;^UTILITY(U,$J,358.3,5980,0)
 ;;=99241^^30^402^1
 ;;^UTILITY(U,$J,358.3,5980,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5980,1,1,0)
 ;;=1^Chart Consult 15 Min or Less
 ;;^UTILITY(U,$J,358.3,5980,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,5981,0)
 ;;=99242^^30^402^2
 ;;^UTILITY(U,$J,358.3,5981,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5981,1,1,0)
 ;;=1^Chart Consult 15-30 Min
 ;;^UTILITY(U,$J,358.3,5981,1,2,0)
 ;;=2^99242
 ;;^UTILITY(U,$J,358.3,5982,0)
 ;;=99243^^30^402^3
 ;;^UTILITY(U,$J,358.3,5982,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5982,1,1,0)
 ;;=1^Chart Consult 30-45 Min
 ;;^UTILITY(U,$J,358.3,5982,1,2,0)
 ;;=2^99243
 ;;^UTILITY(U,$J,358.3,5983,0)
 ;;=414.01^^31^403^7
 ;;^UTILITY(U,$J,358.3,5983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5983,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,5983,1,5,0)
 ;;=5^Atherosclerosis, native coronary
 ;;^UTILITY(U,$J,358.3,5983,2)
 ;;=CAD, Native Vessel^303281
 ;;^UTILITY(U,$J,358.3,5984,0)
 ;;=V58.61^^31^403^3
 ;;^UTILITY(U,$J,358.3,5984,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5984,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,5984,1,5,0)
 ;;=5^Anticoag Rx, chronic
 ;;^UTILITY(U,$J,358.3,5984,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,5985,0)
 ;;=428.0^^31^403^10
 ;;^UTILITY(U,$J,358.3,5985,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5985,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,5985,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,5985,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,5986,0)
 ;;=785.2^^31^403^32
 ;;^UTILITY(U,$J,358.3,5986,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5986,1,4,0)
 ;;=4^785.2
 ;;^UTILITY(U,$J,358.3,5986,1,5,0)
 ;;=5^Undiag Cardiac murmurs
 ;;^UTILITY(U,$J,358.3,5986,2)
 ;;=^295854
 ;;^UTILITY(U,$J,358.3,5987,0)
 ;;=412.^^31^403^28
 ;;^UTILITY(U,$J,358.3,5987,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5987,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,5987,1,5,0)
 ;;=5^Past MI
 ;;^UTILITY(U,$J,358.3,5987,2)
 ;;=Past MI^259884
 ;;^UTILITY(U,$J,358.3,5988,0)
 ;;=443.9^^31^403^25
 ;;
 ;;$END ROU IBDEI0D8
